|
Evaluation of Ejection Fraction in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
|
SMH Adel1    , A Kardooni1 , A Assareh1 , MJ Mohammad Taghizadeh 2 |
1- Department of Cardiovascular Diseases, Atherosclerosis Research Center, Jundishapur University of Medical Sciences, Ahvaz, Iran
2- Department of Cardiovascular Diseases, School of Medicine, Jundishapur University of Medical Sciences, Ahvaz, Iran. , mj.mohammadtaghizadeh@gmail.com |
|
|
Abstract: (511 Views) |
Background & aim: Percutaneous coronary intervention (PCI) is a reperfusion strategy to increase survival and ejection fraction in patients with ST-elevation myocardial infarction (STEMI). Therefore, the aim of the present study was to determine and evaluate the ejection fraction in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Methods: This is a cross-sectional descriptive study that was conducted on 176 patients in Golestan and Imam Khomeini hospitals in Ahvaz in 2022. Patients who underwent angioplasty in the first 12 hours (without receiving fibrinolytic drug) and patients who underwent angioplasty within 12-24 hours after referral (after receiving fibrinolytic drug), 40 days after treatment, all Patients were reevaluated. Patients were compared based on the type of lesion, the number of involved vessels, the type of involved vessel and the location of the lesion in terms of the increase in ejection fraction. Descriptive statistics were used to present quantitative data in the form of mean ± standard deviation and for qualitative variables in the form of percentages, tables and graphs. Chi-square test was used to compare frequency in two groups. T-test was used to compare the mean in two groups. Odds ratio was calculated to compare two groups of case and control in terms of the frequency of each genotype. The collected data were analyzed using Chi-square and t-test.
Results: The most frequent type of lesion diagnosed in patients was type B (61.4%) and the most common vessel involved in patients was the left anterior descending coronary artery (60.2%). The most frequent area involved in the studied patients was diagnosed as anterior (56.8%). There was no significant difference in the increase of jump fraction between the two groups (p=0.2). A marked difference was seen between the ejection fraction, 40 days after treatment based on the involved area (p<0.001), so that at the beginning of the heart attack and before angioplasty, the highest and lowest amount of ejection fraction was observed in patients with involvement, respectively. It was in the posterior region (46.2±5.9) and anterior region (32.2±6.4), after angioplasty regardless of the time, the increase in the second ejection fraction (40 days after myocardial infarction) in patients with obstruction The anterior artery was observed. Correspondingly, the highest rate of ejection fraction was seen in patients with involvement of the right coronary artery (45.7±7) and the lowest amount of ejection fraction was seen in the involvement of the left anterior descending coronary artery (32.4±6.4) (p<0.001). No difference was seen between patients in terms of lesion type (p=0.2). The number of involved vessels had no effect on EF level after treatment (p=0.9) and no significant relationship was observed between the effect of risk factors and EF level (p<0.05).
Conclusion: Based on the results of the present study, the left anterior descending coronary artery and the anterior region were the most involved areas in ST-segment elevation myocardial infarction patients, which led to a further decrease in the ejection fraction. Furthermore, after angioplasty, a greater increase in the second ejection fraction was observed (40 days after a heart attack).
|
|
| Keywords: angioplasty, ejection fraction, Percutaneous coronary intervention. |
|
|
Full-Text [PDF 547 kb]
(68 Downloads)
|
Type of Study: Research |
Subject:
Clinical Surgery
Received: 2023/05/3 | Accepted: 2023/07/15 | Published: 2023/09/9
|
|
|
|
|
|
|
| References |
|
1. Kim MC, Kini AS, Fuster V. Definitions of acute coronary syndromes. Hurst's The Heart. 13th ed. New York: The McGraw-Hill Companies, Inc; 2011L1287-95.## 2. Ozaki Y, Hara H, Onuma Y, Katagiri Y, Amano T, Kobayashi Y, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022. Cardiovascular Intervention and Therapeutics 2022; 37: 1-34. ## [ DOI:10.1007/s12928-021-00829-9] [ PMID] [ ] 3. Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. The Lancet 2017; 389(10065): 197-210. ## [ DOI:10.1016/S0140-6736(16)30677-8] [ PMID] 4. Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, et al. Complete revascularization with multivessel PCI for myocardial infarction. New England Journal of Medicine 2019; 381(15): 1411-21. ## [ DOI:10.1056/NEJMoa1907775] [ PMID] 5. Chan D, Ng LL. Biomarkers in acute myocardial infarction. BMC Medicine 2010; 8(1): 1-11. ## [ DOI:10.1186/1741-7015-8-34] [ PMID] [ ] 6. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. New England Journal of Medicine 2010; 362(23): 2155-65. ## [ DOI:10.1056/NEJMoa0908610] [ PMID] 7. Mythili S, Malathi N. Diagnostic markers of acute myocardial infarction. Biomedical Reports 2015; 3(6): 743-8. ## [ DOI:10.3892/br.2015.500] [ PMID] [ ] 8. Manchurov V, Ryazankina N, Khmara T, Skrypnik D, Reztsov R, Vasilieva E, et al. Remote Ischemic Preconditioning and Endothelial Function in Patients with Acute Myocardial Infarction and Primary PCI. The American Journal of Medicine 2014; 127(7): 670-3. ## [ DOI:10.1016/j.amjmed.2014.02.012] [ PMID] 9. Brezinov OP, Klempfner R, Zekry SB, Goldenberg I, Kuperstein R. Prognostic value of ejection fraction in patients admitted with acute coronary syndrome: A real world study. Medicine 2017; 96(9): e6226. ## [ DOI:10.1097/MD.0000000000006226] [ PMID] [ ] 10. Perazzolo Marra M, Lima JA, Iliceto S. MRI in acute myocardial infarction. European Heart Journal 2011; 32(3): 284-93. ## [ DOI:10.1093/eurheartj/ehq409] [ PMID] 11. Pedersen F, Butrymovich V, Kelbæk H, Wachtell K, Helqvist S, Kastrup J, et al. Short-and long-term cause of death in patients treated with primary PCI for STEMI. Journal of the American College of Cardiology 2014; 64(20): 2101-8. ## [ DOI:10.1016/j.jacc.2014.08.037] [ PMID] 12. Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, et al. Cyclosporine before PCI in patients with acute myocardial infarction. New England Journal of Medicine 2015; 373(11): 1021-31. ## [ DOI:10.1056/NEJMoa1505489] [ PMID] 13. Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. Journal of the American College of Cardiology 2010; 56(4): 254-63. ## [ DOI:10.1016/j.jacc.2010.05.008] [ PMID] 14. Fernando H, Dinh D, Duffy SJ, Brennan A, Sharma A, Clark D, et al. Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry. IJC Heart & Vasculature 2021; 33: 100745. ## [ DOI:10.1016/j.ijcha.2021.100745] [ PMID] [ ] 15. Yeh RW, Kereiakes DJ, Steg PG, Windecker S, Rinaldi MJ, Gershlick AH, et al. Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction. Journal of the American College of Cardiology 2015; 65(20): 2211-21. ## [ DOI:10.1016/j.jacc.2015.03.003] [ PMID] [ ] 16. Ottervanger JP, Ramdat Misier AR, Dambrink JHE, de Boer MJ, Hoorntje JCA, Gosselink ATM, et al. Mortality in patients with left ventricular ejection fraction ≤30% after primary percutaneous coronary intervention for st-elevation myocardial infarction. The American Journal of Cardiology 2007; 100(5): 793-7. ## [ DOI:10.1016/j.amjcard.2007.03.101] [ PMID] 17. Bellandi B, Zocchi C, Xanthopoulou I, Scudiero F, Valenti R, Migliorini A, et al. Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI. International Journal of Cardiology 2016; 221: 567-71. ## [ DOI:10.1016/j.ijcard.2016.06.204] [ PMID] 18. Pedrazzini Giovanni B, Radovanovic D, Vassalli G, Sürder D, Moccetti T, Eberli F, et al. Primary percutaneous coronary intervention for unprotected left main disease in patients with acute st-segment elevation myocardial infarction. JACC: Cardiovascular Interventions 2011; 4(6): 627-33. ## [ DOI:10.1016/j.jcin.2011.04.004] [ PMID] 19. Roe Matthew T, Messenger John C, Weintraub William S, Cannon Christopher P, Fonarow Gregg C, Dai D, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. Journal of the American College of Cardiology 2010; 56(4): 254-63. ## [ DOI:10.1016/j.jacc.2010.05.008] [ PMID] 20. Dracup K, Moser DK, McKinley S, Ball C, Yamasaki K, Kim C-J, et al. An International perspective on the time to treatment for acute myocardial infarction. Journal of Nursing Scholarship 2003; 35(4): 317-23. ## [ DOI:10.1111/j.1547-5069.2003.00317.x] [ PMID] 21. Lombardi F, Sandrone G, Pernpruner S, Sala R, Garimoldi M, Cerutti S, et al. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. The American Journal of Cardiology 1987; 60(16): 1239-45. ## [ DOI:10.1016/0002-9149(87)90601-1] [ PMID] 22. Nienhuis MB, Ottervanger JP, Dambrink J-HE, de Boer M-J, Hoorntje JC, Gosselink AM, et al. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction. Coronary Artery Disease 2009; 20(1): 9-14. ## [ DOI:10.1097/MCA.0b013e32831bd875] [ PMID] 23. Alegria JR, Miller TD, Gibbons RJ, Yi Q-L, Yusuf S. Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. American Heart Journal 2007; 154(4): 743-50. ## [ DOI:10.1016/j.ahj.2007.06.020] [ PMID] 24. Tobaldini E, Fiorelli EM, Prado M, Wu MA, Queiroz A, Kara T, et al. Primary PCI is associated with different cardiac autonomic patterns in relation to the site of myocardial infarction. European Journal of Internal Medicine 2015; 26(10): 792-7. ## [ DOI:10.1016/j.ejim.2015.09.016] [ PMID] 25. Coppola G, Carità P, Corrado E, Borrelli A, Rotolo A, Guglielmo M, et al. ST segment elevations: Always a marker of acute myocardial infarction? Indian Heart Journal 2013; 65(4): 412-23. ## [ DOI:10.1016/j.ihj.2013.06.013] [ PMID] [ ] 26. McNamara Robert L, Kennedy Kevin F, Cohen David J, Diercks Deborah B, Moscucci M, Ramee S, et al. Predicting In-Hospital Mortality in Patients With Acute Myocardial Infarction. Journal of the American College of Cardiology 2016; 68(6): 626-35. ## [ DOI:10.1016/j.jacc.2016.05.049] [ PMID] 27. Sjøli B, Ørn S, Grenne B, Vartdal T, Smiseth OA, Edvardsen T, et al. Comparison of left ventricular ejection fraction and left ventricular global strain as determinants of infarct size in patients with acute myocardial infarction. Journal of the American Society of Echocardiography 2009; 22(11): 1232-8. ## [ DOI:10.1016/j.echo.2009.07.027] [ PMID] 28. Bloch Thomsen PE, Jons C, Raatikainen MJ, Moerch Joergensen R, Hartikainen J, Virtanen V, et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation 2010; 122(13): 1258-64. ## [ DOI:10.1161/CIRCULATIONAHA.109.902148] [ PMID] 29. Cannon CP. Evidence-based risk stratification to target therapies in acute coronary syndromes. Am Heart Assoc 2002; 106(13): 1588-91. ## [ DOI:10.1161/01.CIR.0000030416.80014.F4] [ PMID] 30. 30Wallentin L, Goldstein P, Armstrong P, Granger C, Adgey A, Arntz H, et al. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 2003; 108(2): 135-42. ## [ DOI:10.1161/01.CIR.0000081659.72985.A8] [ PMID] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Adel S, Kardooni A, Assareh A, Mohammad Taghizadeh M. Evaluation of Ejection Fraction in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. armaghanj 2023; 28 (5) :673-688 URL: http://armaghanj.yums.ac.ir/article-1-3479-en.html
|
